• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Erenumab for migraine prevention in a patient with mitochondrial encephalopathy, lactate acidosis, and stroke-like episodes syndrome: A case report.

作者信息

Naegel Steffen, Burow Philipp, Holle Dagny, Stoevesandt Dietrich, Heintz Simon, Thaele Annemarie, Zierz Stephan, Kraya Torsten

机构信息

Department of Neurology, Martin Luther University Halle-Wittenberg, University Hospital Halle, Halle (Saale), Germany.

Department of Neurology, West German Headache Center, University of Duisburg-Essen, Essen, Germany.

出版信息

Headache. 2021 Apr;61(4):694-696. doi: 10.1111/head.14101. Epub 2021 Mar 29.

DOI:10.1111/head.14101
PMID:33779998
Abstract
摘要

相似文献

1
Erenumab for migraine prevention in a patient with mitochondrial encephalopathy, lactate acidosis, and stroke-like episodes syndrome: A case report.依瑞奈尤单抗用于预防线粒体脑病、乳酸酸中毒和卒中样发作综合征患者偏头痛：一例报告
Headache. 2021 Apr;61(4):694-696. doi: 10.1111/head.14101. Epub 2021 Mar 29.
2
Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy.意大利中部阿布鲁佐地区依瑞奈umab 的疗效和安全性的真实数据。
J Headache Pain. 2020 Apr 7;21(1):32. doi: 10.1186/s10194-020-01102-9.
3
Erenumab: First Global Approval.依瑞奈尤单抗：全球首次获批。
Drugs. 2018 Jul;78(11):1157-1161. doi: 10.1007/s40265-018-0944-0.
4
Extreme ecchymoses in a migraine patient using concomitant treatment with calcitonin gene-related peptide receptor antibodies and fish oil supplements: a case report.偏头痛患者同时使用降钙素基因相关肽受体抗体和鱼油补充剂治疗后出现严重瘀斑：一例报告。
BMC Neurol. 2021 Jul 2;21(1):257. doi: 10.1186/s12883-021-02294-6.
5
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions.依那西普单抗（一种新型降钙素基因相关肽受体拮抗剂，用于偏头痛预防）的长期耐受性和非血管安全性：四项安慰剂对照试验的长期扩展合并分析。
Cephalalgia. 2019 Dec;39(14):1798-1808. doi: 10.1177/0333102419888222. Epub 2019 Nov 10.
6
Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study.依瑞奈尤单抗治疗日本偏头痛患者的预防作用：一项 3 期、随机、双盲、安慰剂对照研究的疗效和安全性结果。
Headache. 2021 Jun;61(6):927-935. doi: 10.1111/head.14138. Epub 2021 Jun 21.
7
Molecular Insight into Recognition of the CGRPR Complex by Migraine Prevention Therapy Aimovig (Erenumab).偏头痛预防治疗药物 Aimovig（依瑞奈尤单抗）识别 CGRPR 复合物的分子机制研究
Cell Rep. 2020 Feb 11;30(6):1714-1723.e6. doi: 10.1016/j.celrep.2020.01.029.
8
Erenumab: from scientific evidence to clinical practice-the first Italian real-life data.依瑞奈尤单抗：从科学证据到临床实践——意大利的首批真实世界数据
Neurol Sci. 2019 May;40(Suppl 1):177-179. doi: 10.1007/s10072-019-03839-x.
9
Safety and tolerability of calcitonin-gene-related peptide binding monoclonal antibodies for the prevention of episodic migraine - a meta-analysis of randomized controlled trials.降钙素基因相关肽结合单克隆抗体预防阵发性偏头痛的安全性和耐受性-随机对照试验的荟萃分析。
Cephalalgia. 2019 Aug;39(9):1164-1179. doi: 10.1177/0333102419829007. Epub 2019 Feb 21.
10
Erenumab Side Effects.依瑞奈尤单抗的副作用。
Headache. 2019 Jul;59(7):1088-1089. doi: 10.1111/head.13589.

引用本文的文献

1
Genetic migraine disorders and the response to calcitonin gene-related peptide antagonist treatment.遗传性偏头痛疾病与降钙素基因相关肽拮抗剂治疗的反应
Headache. 2025 Jun;65(6):1041-1043. doi: 10.1111/head.14942. Epub 2025 May 8.
2
Migraine and Stroke: A Scoping Review.偏头痛与中风：一项范围综述
J Clin Med. 2024 Sep 11;13(18):5380. doi: 10.3390/jcm13185380.
3
[Migraine and mitochondrial diseases : Energy deficit in the brain].[偏头痛与线粒体疾病：大脑中的能量缺乏]
Nervenarzt. 2024 Feb;95(2):169-178. doi: 10.1007/s00115-024-01622-8.
4
[Migraine and mitochondrial diseases : Energy deficit in the brain].[偏头痛与线粒体疾病：大脑中的能量不足]
Schmerz. 2023 Dec;37(6):473-482. doi: 10.1007/s00482-023-00764-z. Epub 2023 Nov 3.
5
Ten open questions in migraine prophylaxis with monoclonal antibodies blocking the calcitonin-gene related peptide pathway: a narrative review.阻断降钙素基因相关肽通路的单克隆抗体治疗偏头痛预防的 10 个开放性问题：叙述性综述。
J Headache Pain. 2023 Aug 1;24(1):99. doi: 10.1186/s10194-023-01637-7.
6
Case report: Monoclonal CGRP-antibody treatment in a migraine patient with a mutation in the mitochondrial single-strand binding protein (SSBP1).病例报告：线粒体单链结合蛋白（SSBP1）突变的偏头痛患者接受单克隆降钙素基因相关肽抗体治疗。
Front Neurol. 2022 Sep 15;13:958463. doi: 10.3389/fneur.2022.958463. eCollection 2022.
7
Preventive migraine treatment in mitochondrial diseases: a case report of erenumab efficacy and literature review.线粒体病的预防性偏头痛治疗：依那西普疗效的病例报告及文献复习。
Neurol Sci. 2022 Dec;43(12):6955-6959. doi: 10.1007/s10072-022-06391-3. Epub 2022 Sep 13.
8
Real-World Patient Experience of CGRP-Targeting Therapy for Migraine: a Narrative Review.偏头痛靶向治疗的真实世界患者体验：叙事性综述。
Curr Pain Headache Rep. 2022 Oct;26(10):783-794. doi: 10.1007/s11916-022-01077-z. Epub 2022 Sep 5.